<DOC>
	<DOCNO>NCT01088282</DOCNO>
	<brief_summary>Surgical correction presbyopia possible via implantation multifocal intraocular lens removal crystalline lens . The cost implant approximately 6 time higher conventional monofocal implant routinely use crystalline surgery correction result ametropia . Spectacles correct presbyopia , necessary insertion monofocal implant , may also significant cost . The propose trial involve two randomized group patient need crystalline/cataract surgery , monofocal multifocal lens implant ( type lens eye ) leave emmetropic distant vision . The objective corroborate blind-evaluation effectiveness multifocal lens implant obviate need glass correct presbyopia , evaluate benefit type implant , global economic term ( add cost implant corrective glass necessary ) term improve quality life patient , confirm absence adverse effect . Findings subject statistical quantification .</brief_summary>
	<brief_title>Visual Economic Profits ReSTORÂ® Multifocal Intraocular Lenses ( IOL ) Public Health Patients Spain</brief_title>
	<detailed_description />
	<mesh_term>Presbyopia</mesh_term>
	<criteria>Patients sex age 50 , fullyestablished presbyopia , require phacoemulsification + IOL surgical technique removal cataract . Their capsular bag stable , keratometric astigmatism equal low 1 diopter . Biometric calculation indicate IOL emmetropy within common dioptric range lens , i.e . +6 +34 . Previous corneal refractive surgery Maculopathy , amblyopia eye condition limit visual power Occupations require special driving license Keratometric astigmatism high 1 diopter Any intraoperative posterior capsular rupture extracapsular reconversion .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Diffractive multifocal IOL</keyword>
</DOC>